Nagpur, Maharashtra, India
+919730867604
 Nagpur, Maharashtra, India
+919730867604
+917218129896

USA, UK, Canada, Australia, New Zealand, Germany, France, Italy, Spain, Portugal, Netherlands, Belgium, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Ireland, Poland, Czech Republic, Hungary, Romania, Greece, Turkey, UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain, Jordan, Israel, Japan, South Korea, Singapore, Malaysia, Thailand, Vietnam, Indonesia, Philippines, China, Taiwan, Hong Kong, India, Bangladesh, Sri Lanka, Nepal, South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Ethiopia, Egypt, Morocco, Algeria, Tunisia, Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Uruguay, Paraguay, Mexico, Costa Rica, Panama, Dominican Republic, Jamaica, Fiji, and Mauritius.

Welcome to BizHQ, a pharmaceutical information platform providing product specifications, packaging details, and international regulatory information.

Hexabol 76.5 mg/ml is labeled as an injectable preparation containing Trenbolone Hexahydrobenzylcarbonate, a synthetic anabolic-androgenic steroid.

The product packaging displays British Pharma branding and identifies the formulation as a 10 ml multidose vial intended for intramuscular administration.

Product Specifications

Product DetailsInformation
Product NameHexabol
Generic NameTrenbolone Hexahydrobenzylcarbonate
Strength76.5 mg/ml
Dosage FormInjectable Solution
Packaging10 ml Multidose Vial
Brand MarkingBritish Pharma
Route on LabelIntramuscular
CategoryAnabolic-Androgenic Steroid
Prescription MarkingRx Only

Specifications are based on the supplied product image and are not independently authenticated.

International Regulatory Information

Regulatory considerations for Hexabol and trenbolone compounds may be relevant to pharmaceutical professionals researching requirements in the following countries:

North America: United States, Canada, Mexico

Europe: United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Norway, Denmark, Poland, Portugal, Ireland, Austria, Greece

Middle East: United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain

Asia: Japan, South Korea, Singapore, Malaysia, Thailand, Vietnam, Philippines, Indonesia

Oceania: Australia, New Zealand

Africa: South Africa, Kenya, Nigeria, Ghana, Tanzania, Uganda

South America: Brazil, Argentina, Chile, Colombia, Peru

These countries are included for informational and regulatory research purposes only. Their inclusion does not imply product approval, availability, or permission to import or distribute Hexabol.

Pharmaceutical Documentation and Compliance

Licensed pharmaceutical organizations assessing regulated medicines should verify the following documentation where applicable:

  • Manufacturer and product authenticity records

  • Certificate of Analysis (COA)

  • GMP documentation

  • Product registration or marketing authorization

  • Import and export permits

  • Controlled-substance licenses

  • Batch and expiry information

Importation and distribution must comply with the relevant laws of both the exporting and destination countries.

Safety and Regulatory Precautions

Trenbolone Hexahydrobenzylcarbonate is not FDA-approved for human medical use in the United States.

Potential health risks include cardiovascular complications, hormonal suppression, reproductive problems, and adverse psychological effects.

This product should not be promoted for bodybuilding, athletic performance enhancement, or unsupervised human use.

Frequently Asked Questions

Q1. What is Hexabol 76.5 mg/ml?

Hexabol is labeled as an injectable product containing Trenbolone Hexahydrobenzylcarbonate at 76.5 mg/ml.

Q2. What packaging is shown?

The supplied product image shows a 10 ml multidose vial.

Q3. Is Hexabol approved in every international market?

No. Approval cannot be assumed. Product registration and legal status must be verified separately in each country.

Q4. Can controlled anabolic steroids be internationally distributed?

Only where legally permitted and with all applicable pharmaceutical and controlled-substance authorizations.

Q5. What should pharmaceutical professionals verify before evaluating this product?

They should confirm the product's identity, authenticity, regulatory classification, approval status, and relevant manufacturer documentation.

Contact BizHQ

For pharmaceutical product information, regulatory enquiries, and general professional correspondence:

Company Name: BizHQ

Website: https://medicineindiaexport.com

WhatsApp / Contact: +91 9209725630

Location: India

 2026-11-18T07:08:29

Other Pages

View all pages